Skip to content
Trial Eligibility
Menu

1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

NCT07155239

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Hidradenitis suppurativa (HS) is a long-lasting skin condition that causes painful lumps, abscesses, and tunnels in areas such as the armpits and groin. HS begins around the hair follicle; when the follicle becomes blocked and inflamed, new lesions form. Prior clinical studies of lasers that act on the hair follicle have shown improvement in HS symptoms, and a 1726-nm diode laser-designed to selectively heat oil glands within the follicle-has reduced inflammatory lesions in acne with good tolerability across many skin types.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Hidradenitis Suppurativa (HS)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 60 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Wynn Medical Center
Last updated on ClinicalTrials.gov
September 17, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Wynn Medical Center Rheumatology/Dermatology · Rosemead, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.